Aviles-Olmos, I; Dickson, J; Kefalopoulou, Z; Djamshidian, A; Kahan, J; Ell, P; Whitton, P; ... Foltynie, T; + view all Aviles-Olmos, I; Dickson, J; Kefalopoulou, Z; Djamshidian, A; Kahan, J; Ell, P; Whitton, P; Wyse, R; Isaacs, T; Lees, A; Limousin, P; Foltynie, T; - view fewer (2014) Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease. Journal of Parkinson’s Disease , 4 (3) 337 - 344. 10.3233/JPD-140364.